Clinical Trials Sponsored by MEDA Pharma GmbH & Co. KG

Total 268 results

MEDA Pharma GmbH & Co. KG

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

DYmista NAsal Spray in CHInese Patients (DYNAS-CHI)

Allergic Rhinitis

China
MEDA Pharma GmbH & Co. KG

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA)

Actinic Keratosis

Austria, Germany, France
MEDA Pharma GmbH & Co. KG

Completed

To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Atrial Fibrillation

France
MEDA Pharma GmbH & Co. KG

Completed

Dymista Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

Aldara for the Treatment of Large and/or Multiple sBCC

Carcinoma, Basal Cell

France
MEDA Pharma GmbH & Co. KG

Completed

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Germany
MEDA Pharma GmbH & Co. KG

Completed

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Genital Warts

Italy
MEDA Pharma GmbH & Co. KG

Completed

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Actinic Keratosis

France
MEDA Pharma GmbH & Co. KG

Recruiting

Real-world Evidence Study on Cystistat (IC/BPS)

Interstitial Cystitis and Bladder Pain Syndrome

Austria
MEDA Pharma GmbH & Co. KG

Completed

Azelastine Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

Basal Cell Carcinoma

Germany
MEDA Pharma GmbH & Co. KG

Completed

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Actinic Keratoses
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
MEDA Pharma GmbH & Co. KG

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

Diabetic Polyneuropathy

Israel, Russian Federation
Nantes University Hospital
MEDA Pharma GmbH & Co. KG

Completed

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face (ImiReduc)

Lentigo Maligna Melanoma (Head or Neck)

France
MEDA Pharma GmbH & Co. KG
3M

Terminated

Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

Atrial Fibrillation

Belgium, Bulgaria, France, Germany, Netherlands, Romania, Spain
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Prolytic GmbH; pharm-analyt GmbH

Completed

Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays

Allergic Rhinitis

Germany
MEDA Pharma GmbH & Co. KG
Sanofi; ClinResearch, GmbH

Completed

To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol (AERIA)

Asthma, Exercise-Induced

Germany
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Prolytic GmbH

Completed

Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays

Allergic Rhinitis

Germany
Maastricht University Medical Center
MEDA Pharma GmbH & Co. KG

Terminated

Imiquimod Treatment of CIN Lesions (TOPIC)

Cervical Intraepithelial Neoplasia

Netherlands
Mylan Inc.
MEDA Pharma GmbH & Co. KG

Completed

Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients

Allergic Rhinitis

Taiwan, Thailand, Malaysia, Hong Kong
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Cassella-med GmbH & Co. KG

Completed

St. John's Wort Extract LI 160 for the Treatment of Atypical Depression

Atypical Depression
Mucos Pharma GmbH & Co. KG

Completed

Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance

Thrombophlebitis Leg

Italy
Mucos Pharma GmbH & Co. KG

Completed

Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise (2012-005003-40)

Muscle Soreness | Muscle Injury | Exercise Induced Muscle Damage

Germany
Federal University Teaching Hospital, Feldkirch...
MEDA Pharma GmbH & Co. KG

Completed

Imiquimod and Actinic Keratoses: an Observational Study

Actinic Keratosis
University Hospital, Ghent
MEDA Pharma GmbH & Co. KG; University of Wuerzburg

Withdrawn

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

Bioavailability Study

Belgium
MEDA Pharma GmbH & Co. KG
Quintiles, Inc.; Ergomed; Clinquest, Inc.

Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) (NATHAN1)

Diabetic Polyneuropathy

United States, Spain, Croatia, Denmark, France, Italy, Netherlands, Sweden, United Kingdom
MEDA Pharma GmbH & Co. KG
Accovion GmbH; Siro Clinpharm Germany GmbH (until June 2013)

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (LEIDA 2)

Actinic Keratosis

Austria, Germany
MEDA Pharma GmbH & Co. KG
ICON plc; Clinipace Worldwide; Trium Analysis Online GmbH

Terminated

Tepilta® Versus Oxetacaine, Antacids and Placebo

Radiation-induced Oesophagitis

Germany, Austria
Mucos Pharma GmbH & Co. KG
Nestlé; Artialis

Completed

Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis (WobeSmart)

Osteoarthritis

Belgium
Diabetes Schwerpunktpraxis
Woerwag Pharma GmbH & Co. KG

Unknown

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

Diabetic Neuropathies

Germany
Westfälische Wilhelms-Universität Münster
photonamic GmbH & Co. KG; medac GmbH

Recruiting

Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors

Brain Tumor, Pediatric

Germany, Netherlands
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Epidermolysis Bullosa

Austria
Oryx GmbH & Co. KG

Completed

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. (ParvOryx01)

Glioblastoma Multiforme

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Prediction Equations for BIA of the Elderly

Healthy Elderly

Germany
photonamic GmbH & Co. KG

Completed

5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities

Actinic Keratoses

Germany
Apceth GmbH & Co. KG

Terminated

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 (TREAT-ME 1)

Advanced Gastrointestinal Cancer

Germany
Cytonet GmbH & Co. KG

Completed

Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders

Ornithine Transcarbamylase Deficiency | Urea Cycle Disorders | Citrullinemia | Carbamoylphosphate Synthetase I Deficiency

Germany
Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Allergic Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Allergic Asthma | Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Allergic Rhinoconjunctivitis

Sweden
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Birch Pollen Allergy

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Normal Ranges to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)

Healthy

Germany
Seca GmbH & Co. Kg.

Completed

Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)

Kidney Diseases

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Prediction Equations to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)

Bioelectrical Impedance Measurement of Healthy Adults

Germany
Cytonet GmbH & Co. KG

Completed

Study to Evaluate 13 C Isotope Ratio Measurement for Urea Cycle Capacity Assessment

Urea Cycle Disorders

Germany
photonamic GmbH & Co. KG

Recruiting

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Glioblastoma

Germany

3

Subscribe